Literature DB >> 27803886

Bepotastine-induced urticaria, cross-reactive with other antihistamines.

Ju Wan Kang1, Jaechun Lee2.   

Abstract

Second-generation antihistamines are widely prescribed for the control of symptoms of allergic inflammation such as itchy hives, coryza, and itchy eyes. In rare circumstances, these drugs might provoke allergic inflammation. Hypersensitivity to bepotastine besilate, a second-generation antihistamine has never been reported. A 17-year-old schoolgirl, whose paroxysmal itchy hives had been controlled with bepotastine, experienced aggravation of the hives. An oral provocation test confirmed her hypersensitivity to bepotastine and cross-reactivity to levocetirizine. She showed no reaction to chlorpheniramine, ketotifen, or olopatadine among the 13 antihistamines tested. While searching for an antihistamine to control her itchy hives, we found that she also exhibited cross-reactivity to various antihistamines with different chemical structures from that of bepotastine, which is not predicted according to the chemical classification of antihistamines. We report a case of hypersensitivity to bepotastine besilate in a patient with chronic spontaneous urticaria.

Entities:  

Keywords:  Cross-reactions; Drug hypersensitivity; Histamine antagonists; Urticaria

Year:  2016        PMID: 27803886      PMCID: PMC5088262          DOI: 10.5415/apallergy.2016.6.4.253

Source DB:  PubMed          Journal:  Asia Pac Allergy        ISSN: 2233-8276


  8 in total

1.  Urticaria induced by cetirizine.

Authors:  D Calista; S Schianchi; M Morri
Journal:  Br J Dermatol       Date:  2001-01       Impact factor: 9.302

2.  Cetirizine-induced urticarial reaction.

Authors:  T Karamfilov; A Wilmer; U C Hipler; U Wollina
Journal:  Br J Dermatol       Date:  1999-05       Impact factor: 9.302

3.  A case of urticaria induced by both hydroxyzine and cetirizine but not by levocetirizine.

Authors:  Y-S Chang; H-S Kwon; S-H Cho; Y-Y Kim; K-U Min
Journal:  Allergy       Date:  2007-04-30       Impact factor: 13.146

Review 4.  Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate.

Authors:  Jon I Williams; James A Gow; Sharon M Klier; Shannon L McCue; Anne Marie F Salapatek; Timothy R McNamara
Journal:  Curr Med Res Opin       Date:  2010-10       Impact factor: 2.580

5.  Urticaria caused by antihistamines: report of 5 cases.

Authors:  P Rodríguez del Río; M L González-Gutiérrez; J Sánchez-López; B Nuñez-Acevedo; J M Bartolomé Alvarez; C Martínez-Cócera
Journal:  J Investig Allergol Clin Immunol       Date:  2009       Impact factor: 4.333

6.  Multiple H1-antihistamine-induced urticaria.

Authors:  Naoko Inomata; Satoko Tatewaki; Zenro Ikezawa
Journal:  J Dermatol       Date:  2009-04       Impact factor: 4.005

7.  Fexofenadine-induced urticaria.

Authors:  Sang Woo Lee; Ji Yeon Byun; You Won Choi; Ki Bum Myung; Hae Young Choi
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444

8.  A case of levocetirizine-induced fixed drug eruption and cross-reaction with piperazine derivatives.

Authors:  Mi-Yeong Kim; Eun-Jung Jo; Yoon-Seok Chang; Sang-Heon Cho; Kyung-Up Min; Sae-Hoon Kim
Journal:  Asia Pac Allergy       Date:  2013-10-31
  8 in total
  1 in total

1.  Chlorpheniramine-induced anaphylaxis: Two case reports and a retrospective review of pharmacovigilance database.

Authors:  So-Hee Lee; Youngsoo Lee; Seong-Dae Woo; Ko-Eun Doo; Chae-Yeon Ha; Young-Hee Lee; Young-Min Ye
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.